Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Plasma Medicine

ISSN Print: 1947-5764
ISSN Online: 1947-5772

Plasma Medicine

DOI: 10.1615/PlasmaMed.2014006273
pages 85-96

Reasons Why We Need Cold Atmospheric Plasmas in Bacteria-Related Diseases in Medicine

Georg Isbary
Department of Dermatology, Allergology, and Environmental Medicine, Hospital Munich, Munich, Germany
Julia Luise Zimmermann
terraplasma GmbH, Garching, Germany; Max-Planck Institute for Extraterrestrial Physics, Garching, Germany
Tetsuji Shimizu
Max Planck Institute for Extraterrestrial Physics, Garching, Germany
Gregor Ego Morfill
Max Planck Institute for extraterrestrial Physics, Giessenbachstrasse, D-85471 Garching, Germany
Anindita Mitra
Max Planck Institute for Extraterrestrial Physics, Garching, Germany
Hubertus Maria Thomas
Max Planck Institute for Extraterrestrial Physics, Garching, Germany
Tobias Gabriel Klampfl
Max Planck Institute for Extraterrestrial Physics, Garching, Germany; Department of Pathology, Technical University of Munich, Munich, Germany
Julia Koeritzer
Max Planck Institute for Extraterrestrial Physics, Garching, Germany; Department of Pathology, Technical University of Munich, Munich, Germany
Veronika Boxhammer
Max Planck Institute for Extraterrestrial Physics, Garching, Germany; Department of Pathology, Technical University of Munich, Munich, Germany
Jurgen Schlegel
Department of Pathology, Technical University of Munich, Munich, Germany
Wilhelm Stolz
Department of Dermatology, Allergology, and Environmental Medicine, Hospital Munich, Munich, Germany

ABSTRACT

Upcoming technologies for medical purposes must demonstrate their unique features and benefits compared with other methods in use. Cold atmospheric plasma technology has unique properties regarding antimicrobial purposes, owing to the numerous ways to generate and design the plasma. To date, no primary resistance against any tested microbes has been found. Furthermore, several tests and theoretical calculations show the unlikelihood of microbes acquiring resistance against cold atmospheric plasma. The latter fact is the main advantage of cold atmospheric plasma technology compared with conventional antimicrobial products (e.g., antibiotics) available in the medical sector, whose more or less uncontrolled usage has led to global resistance concerns and possibly to a lack of future treatment approaches.